Brain scans reveal hidden effects of childhood cancer treatment
NCT ID NCT03208387
First seen Jun 24, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study looks at how surviving a pediatric brain tumor affects thinking and behavior. Researchers will use brain scans to examine brain structure in children who have completed treatment. The goal is to better understand the long-term cognitive challenges these survivors may face.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify brain changes linked to cognitive problems in pediatric brain tumor survivors, guiding future support strategies.
- What could go wrong
- This is a small pilot study with only 42 participants, focused on feasibility. It may not produce definitive results or directly lead to treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
42 people
The number who actually took part.
- Started
-
Jun 2017
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be recruited at MSK and three participating sites (Columbia University, University of Washington and University of Texas Southwestern).
- Ages
-
6 to 16 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Children Treated for Posterior Fossa Tumors: * As per medical record or clinical report, successfully completed all medical treatment for either an M0 posterior fossa medulloblastoma without dissemination or posterior fossa low-grade astrocytoma without relapse or evidence of residual disease. * For medulloblastoma survivors only: Previously treated with gross total resection (GTR), craniospinal irradiation with conformal posterior fossa boost radiotherapy (CSI + Boost) and chemotherapy * For low grade astrocytoma survivors only: Previously treated with gross total resection ONLY (no chemotherapy or radiotherapy). * As per medical record or clinician report, between 1-10 years post completion of their medical treatment for their posterior fossa brain tumor. * Subject is between the ages of 6 through 16 years at time of consent. * As per medical record or parent report, subject is able to tolerate an MRI without sedation. Healthy Control Participants: * No major medical illness, as determined by medical interview by study physician. * As per parent report, subject is between the ages of 6 through 16 years at time of consent. * As per parent report, subject is able to tolerate an MRI without sedation. Exclusion Criteria: All Participants: * Full Scale IQ as documented to be below a standard score of \<70 based upon the study IQ assessment completed after consent. * As per self or parent report, completed any portion of the neuropsychological battery used in this study within the last year. * MRI contraindications (e.g., implanted ferromagnetic devices, claustrophobia) as per radiology clinical operating procedures. * As per self or parent report or medical record, currently taking medications that have CNS effects (i.e., antidepressants, neuroleptics, anti-seizure medications, drugs that affect blood pressure or heart rate, alpha-agonists, adrenergic blockers, lithium, sedating antihistamines, and some medications for the treatment of asthma). * As per self or parent report, non-fluency in English language as demonstrated by current educational placement in a non-English-speaking classroom setting.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University
New York, New York, 10032, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75235, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore lost vision
- Can freezing ovarian tissue protect fertility in children facing cancer treatment?
- Brain surgery delirium: can real-time monitoring protect older patients?
- Tumor profiling may unlock targeted drug options for pediatric cancers
- Can a new pill tame childhood cancers that Won't quit?
- A bike ride could reveal hidden heart risks in young cancer survivors